Market Overview

NanoString Technologies Names Dale R. Levitzke Vice President of Global Sales for Life Sciences

Related ILMN
Illumina Reported Its Fastest Top-line Growth Since 2015
Benzinga's Top Upgrades, Downgrades For October 25, 2017
Your Daily Pharma Scoop: Aclaris Gets Approval, Egalet Surges, Alnylam Gains As FDA Lifts Clinical Hold (Seeking Alpha)

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the appointment of Dale R. Levitzke as Vice President of Global Sales, Life Sciences. Mr. Levitzke will be responsible for expanding global sales for NanoString's research products business and associated nCounter® Analysis System, an advanced multi-application technology platform based on digital molecular barcoding.

Mr. Levitzke joins NanoString from Illumina, Inc. (NASDAQ: ILMN) where he was Senior Director and Global Sales Manager for the company's PCR division, created following Illumina's acquisition of Helixis in 2010. In that role, he led all aspects of global sales for Illumina's quantitative real-time PCR product line and established a global distribution network with 38 distributors covering 126 countries. Previously, he headed global sales for Helixis, Inc., a developer of advanced nucleic acid analysis tools for research and applied applications. Mr. Levitzke also held the position of General Manager of Corbett Robotics Inc., establishing the direct sales, administrative and service office for Corbett Life Sciences in the United States. Mr. Levitzke began his career as a research scientist and served as a Core Facility Manager at the University of Newcastle's Analytical and Biomolecular Research Facility. Mr. Levitzke earned a Bachelor of Science with honors degree in molecular biology at La Trobe University Melbourne.

Posted-In: News Management Press Releases


Related Articles (ILMN)

View Comments and Join the Discussion!